A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

NCT07180355 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Friedreich's Ataxia (FA)

Interventions

DRUG: SGT-212

Sponsor

Solid Biosciences Inc.